Core Viewpoint - Weigao Blood Purification is planning to acquire 100% equity of Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. through a share issuance, which is expected to constitute a major asset restructuring and related party transaction, but will not change the actual controller of the company [2][10]. Group 1: Acquisition Details - The acquisition is currently in the planning stage and carries uncertainties [2]. - The stock of Weigao Blood Purification will be suspended from trading starting October 20, with an expected suspension period of no more than 10 trading days [3]. - The acquisition target, Weigao Purui, was established on September 13, 2018, with a registered capital of 106 million yuan, and its business scope includes the manufacturing of medical packaging materials and the production and sale of medical devices [8]. Group 2: Financial Performance - In the first half of 2025, Weigao Blood Purification reported a net profit attributable to shareholders of 220 million yuan, an increase of 10.11% year-on-year [11]. - The company achieved operating revenue of 1.765 billion yuan in the same period, reflecting an 8.52% growth compared to the previous year [12]. - As of the end of the reporting period, the company held 16 Class III medical device product registration certificates, with sales covering all 31 provinces, municipalities, and autonomous regions in China, reaching over 6,000 medical institutions [12]. Group 3: Market Position - Weigao Blood Purification specializes in the research, development, production, and sale of blood purification medical products, including blood dialysis devices and solutions, and is one of the most comprehensive manufacturers in the domestic market [12]. - The company has made significant technological advancements in key membrane technologies for blood dialysis, positioning itself as a leading domestic player in the blood purification industry [12]. - As of October 17, the company's stock closed at 38.61 yuan per share, with a market capitalization of 16.1 billion yuan [13].
筹划重大资产重组！下周一起停牌 上市仅五月